{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["8(9)"],"submitter":["Maswanganyi K"],"pubmed_abstract":["<h4>Background and aims</h4>People with human immunodeficiency virus (PLWHIV) have a higher prevalence of non-communicable diseases (NCDs) such as obesity, diabetes mellitus and cardiovascular diseases (CVDs). Previous studies have depicted that PLWHIV have these NCDs due to the predisposing risk factors of CVDs including dyslipidaemia, impaired fasting glucose, hypertension, obesity, and elevated glycated hemoglobin. Understanding the cumulative consequences of these disorders is critical in this population. Hence, the aim of this protocol is to narrate the methods and techniques that will be used to perform a systematic review and meta-analysis of the prevalence of various CVD risk factors among diabetic individuals receiving antiretroviral therapy. Furthermore, this review will explore "],"journal":["Health science reports"],"pagination":["e71274"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12440799"],"repository":["biostudies-literature"],"pubmed_title":["The Prevalence of Cardiovascular Disease Risk Factors on Diabetic Human Immunodeficiency Virus-Infected Individuals on Antiretroviral Treatment: A Systematic Review and Meta-Analysis Protocol."],"pmcid":["PMC12440799"],"pubmed_authors":["Mzimela NC","Sedibe A","Maswanganyi K","Gamede M"],"additional_accession":[]},"is_claimable":false,"name":"The Prevalence of Cardiovascular Disease Risk Factors on Diabetic Human Immunodeficiency Virus-Infected Individuals on Antiretroviral Treatment: A Systematic Review and Meta-Analysis Protocol.","description":"<h4>Background and aims</h4>People with human immunodeficiency virus (PLWHIV) have a higher prevalence of non-communicable diseases (NCDs) such as obesity, diabetes mellitus and cardiovascular diseases (CVDs). Previous studies have depicted that PLWHIV have these NCDs due to the predisposing risk factors of CVDs including dyslipidaemia, impaired fasting glucose, hypertension, obesity, and elevated glycated hemoglobin. Understanding the cumulative consequences of these disorders is critical in this population. Hence, the aim of this protocol is to narrate the methods and techniques that will be used to perform a systematic review and meta-analysis of the prevalence of various CVD risk factors among diabetic individuals receiving antiretroviral therapy. Furthermore, this review will explore ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Sep","modification":"2026-06-03T10:13:20.005Z","creation":"2026-04-26T03:11:49.183Z"},"accession":"S-EPMC12440799","cross_references":{"pubmed":["40970105"],"doi":["10.1002/hsr2.71274"]}}